{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T09:33:11Z","timestamp":1776159191429,"version":"3.50.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T00:00:00Z","timestamp":1606003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T00:00:00Z","timestamp":1606003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["80-84600-98-3002"],"award-info":[{"award-number":["80-84600-98-3002"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["80-84600-98-3002"],"award-info":[{"award-number":["80-84600-98-3002"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>If genome sequencing is performed in health care, in theory the opportunity arises to take a further look at the data: opportunistic genomic screening (OGS). The European Society of Human Genetics (ESHG) in 2013 recommended that genome analysis should be restricted to the original health problem at least for the time being. Other organizations have argued that \u2018actionable\u2019 genetic variants should or could be reported (including American College of Medical Genetics and Genomics, French Society of Predictive and Personalized Medicine, Genomics England). They argue that the opportunity should be used to routinely and systematically look for secondary findings\u2014so-called opportunistic screening. From a normative perspective, the distinguishing characteristic of screening is not so much its context (whether public health or health care), but the lack of an indication for having this specific test or investigation in those to whom screening is offered. Screening entails a more precarious benefits-to-risks balance. The ESHG continues to recommend a cautious approach to opportunistic screening. Proportionality and autonomy must be guaranteed, and in collectively funded health-care systems the potential benefits must be balanced against health care expenditures. With regard to genome sequencing in pediatrics, ESHG argues that it is premature to look for later-onset conditions in children. Counseling should be offered and informed consent is and should be a central ethical norm. Depending on developing evidence on penetrance, actionability, and available resources, OGS pilots may be justified to generate data for a future, informed, comparative analysis of OGS and its main alternatives, such as cascade testing.<\/jats:p>","DOI":"10.1038\/s41431-020-00758-w","type":"journal-article","created":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T19:02:33Z","timestamp":1606071753000},"page":"365-377","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":132,"title":["Opportunistic genomic screening. Recommendations of the European Society of Human Genetics"],"prefix":"10.1038","volume":"29","author":[{"name":"On behalf of the European Society of Human Genetics","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0410-4902","authenticated-orcid":false,"given":"Guido","family":"de Wert","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4052-7192","authenticated-orcid":false,"given":"Wybo","family":"Dondorp","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1200-9286","authenticated-orcid":false,"given":"Angus","family":"Clarke","sequence":"additional","affiliation":[]},{"given":"Elisabeth M. C.","family":"Dequeker","sequence":"additional","affiliation":[]},{"given":"Christophe","family":"Cordier","sequence":"additional","affiliation":[]},{"given":"Zandra","family":"Deans","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2201-2320","authenticated-orcid":false,"given":"Carla G.","family":"van El","sequence":"additional","affiliation":[]},{"given":"Florence","family":"Fellmann","sequence":"additional","affiliation":[]},{"given":"Ros","family":"Hastings","sequence":"additional","affiliation":[]},{"given":"Sabine","family":"Hentze","sequence":"additional","affiliation":[]},{"given":"Heidi","family":"Howard","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5173-5280","authenticated-orcid":false,"given":"Milan","family":"Macek","sequence":"additional","affiliation":[]},{"given":"Alvaro","family":"Mendes","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4191-0663","authenticated-orcid":false,"given":"Chris","family":"Patch","sequence":"additional","affiliation":[]},{"given":"Emmanuelle","family":"Rial-Sebbag","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4451-3126","authenticated-orcid":false,"given":"Vigdis","family":"Stefansdottir","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5397-5544","authenticated-orcid":false,"given":"Martina C.","family":"Cornel","sequence":"additional","affiliation":[]},{"given":"Francesca","family":"Forzano","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,11,22]]},"reference":[{"key":"758_CR1","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ejhg.2013.46","volume":"21","author":"El,CG Van","year":"2013","unstructured":"Van El, CG, Cornel MC, Borry P, Hastings RJ, Fellmann F, Hodgson SV, et al. Public and Professional Policy Committee (2013). Whole-genome sequencing in health care: recommendations of the European Society of Human Genetics. Eur J Hum Genet. 2013;21:580\u20134.","journal-title":"Eur J Hum Genet."},{"key":"758_CR2","first-page":"284","volume":"25","author":"German Society of Human Genetics.","year":"2013","unstructured":"German Society of Human Genetics. Deutsche Gesellschaft f\u00fcr Humangenetik (GfH). Stellungnahme der Deutschen Gesellschaft f\u00fcr Humangenetik zu genetischen Zusatzbefunden in Diagnostik und Forschung. Med Gen. 2013;25:284\u20136.","journal-title":"Med Gen"},{"key":"758_CR3","unstructured":"Health Council of the Netherlands. The Hague: Health Council of the Netherlands, 2015; publication no. 2015\/01. [Executive Summary in English https:\/\/www.gezondheidsraad.nl\/documenten\/adviezen\/2015\/02\/04\/next-generation-sequencing-in-diagnostiek]."},{"key":"758_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1136\/jmedgenet-2015-103144","volume":"52","author":"K Boycott","year":"2015","unstructured":"Boycott K, Hartley T, Adam S, Bernier F, Chong K, Fernandez BA, et al. The clinical application of genome-wide sequencing for monogenic diseases in Canada: Position Statement of the Canadian College of Medical Geneticists. J Med Genet. 2015;52:431\u20137. https:\/\/doi.org\/10.1136\/jmedgenet-2015-103144.","journal-title":"J Med Genet"},{"key":"758_CR5","unstructured":"French Agency of Biomedicine. Projet de recommandations de bonnes pratiques professionnelles en mati\u00e8re de gestion des r\u00e9sultats d\u2019un examen de s\u00e9quen\u00e7age pang\u00e9nomique sans relation directe avec l\u2019indication initiale dans le cadre du soin. https:\/\/www.agence-biomedecine.fr\/IMG\/pdf\/20200107_rbp_donnees_additionnelles_dv.pdf. Accessed 18 Apr 2020."},{"key":"758_CR6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/gim.2013.73","volume":"15","author":"RC Green","year":"2013","unstructured":"Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, et al. American College of Medical Genetics and Genomics. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15:565\u201374.","journal-title":"Genet Med"},{"key":"758_CR7","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1038\/s41431-018-0224-1","volume":"26","author":"P Pujol","year":"2018","unstructured":"Pujol P, Vande Perre P, Faivre L, Sanlaville D, Corsini C, Baertschi B, et al. Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations. Eur J Hum Genet. 2018;26:1732\u201342.","journal-title":"Eur J Hum Genet"},{"key":"758_CR8","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/gim.2013.96","volume":"15","author":"NA Holtzman","year":"2013","unstructured":"Holtzman NA. ACMG recommendations on incidental findings are flawed scientifically and ethically. Genet Med. 2013;15:750\u20131.","journal-title":"Genet Med"},{"key":"758_CR9","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/s41431-019-0438-x","volume":"27","author":"B Isidor","year":"2019","unstructured":"Isidor B, Julia S, Saugier-Veber P, Weil-Dubuc PL, B\u00e9zieau S, Bieth E, et al. Searching for secondary findings: considering actionability and preserving the right not to know. Eur J Hum Genet. 2019;27:1481\u20134. https:\/\/doi.org\/10.1038\/s41431-019-0438-x.","journal-title":"Eur J Hum Genet"},{"key":"758_CR10","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1038\/s41436-019-0572-4","volume":"21","author":"RL Nussbaum","year":"2019","unstructured":"Nussbaum RL, Haverfield E, Esplin ED, Aradhya S. Response to \u201cThe use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG)\u201d. Genet Med. 2019;21:2836\u20137.","journal-title":"Genet Med"},{"key":"758_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12910-020-0452-0","volume":"21","author":"M Saelaert","year":"2020","unstructured":"Saelaert M, Mertes H, Moerenhout T, De Baere E, Devisch I. Ethical values supporting the disclosure of incidental and secondary findings in clinical genomic testing: a qualitative study. BMC Med Ethics. 2020;21:9.","journal-title":"BMC Med Ethics"},{"key":"758_CR12","doi-asserted-by":"crossref","unstructured":"De Wert G, Dondorp W. Opportunistic genomic screening: ethical exploration. In: Tibben A & Biesecker B, editors. Clinical genome sequencing. Psychological considerations. London: Elsevier\/AP; 2019. pp 203\u201324.","DOI":"10.1016\/B978-0-12-813335-4.00012-X"},{"key":"758_CR13","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/jgc4.1102","volume":"28","author":"M Martyn","year":"2019","unstructured":"Martyn M, Kanga-Parabia A, Lynch E, James PA, Macciocca I, Trainer AH, et al. A novel approach to offering additional genomic findings-A protocol to test a two-step approach in the healthcare system. J Genet Couns. 2019;28:388\u201397. https:\/\/doi.org\/10.1002\/jgc4.1102","journal-title":"J Genet Couns"},{"key":"758_CR14","unstructured":"Lynch E, Martyn M, Lee L, Kanga-Parabia A, Weerasuriya R, Tytherleigh R et al. Abstract ESHG Conference 9 June 2020; (Abstract C31.2). https:\/\/www.abstractsonline.com\/pp8\/#!\/9102\/presentation\/138."},{"key":"758_CR15","doi-asserted-by":"publisher","unstructured":"Vears DF, Elferink M, Kriek M, Borry P, van Gassen KL.Analysis of laboratory reporting practices using a quality assessment of a virtual patient. Genet Med. 2020. https:\/\/doi.org\/10.1038\/s41436-020-01015-7. [Epub ahead of print].","DOI":"10.1038\/s41436-020-01015-7"},{"key":"758_CR16","doi-asserted-by":"publisher","first-page":"588","DOI":"10.7326\/0003-4819-158-8-201304160-00003","volume":"158","author":"PJ Pickhardt","year":"2013","unstructured":"Pickhardt PJ, Pooler BD, Lauder T, del Rio AM, Bruce RJ, Binkley N. Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications. Ann Intern Med. 2013;158:588\u201395. https:\/\/doi.org\/10.7326\/0003-4819-158-8-201304160-00003.","journal-title":"Ann Intern Med"},{"key":"758_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/gim.2016.190","volume":"19","author":"SS Kalia","year":"2017","unstructured":"Kalia SS, Adelman K, Bale SJ, Chung WK, Eng C, Evans JP, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med 2017;19:249\u201355.","journal-title":"Genet Med"},{"key":"758_CR18","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/gim.2013.82","volume":"15","author":"American College of Medical Genetics and Genomics.","year":"2013","unstructured":"American College of Medical Genetics and Genomics. Incidental findings in clinical genomics: a clarification. Genet Med. 2013;15:664\u20136.","journal-title":"Genet Med"},{"key":"758_CR19","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1126\/science.1240156","volume":"340","author":"AL McGuire","year":"2013","unstructured":"McGuire AL, Joffe S, Koenig BA, Biesecker BB, McCullough LB, Blumenthal-Barby JS. et al. Point-counterpoint. Ethics and genomic incidental findings. Science. 2013;340:1047\u20138.","journal-title":"Science"},{"key":"758_CR20","unstructured":"NHS: https:\/\/www.england.nhs.uk\/genomics\/nhs-genomic-med-service\/. Accessed 18 Apr 2020."},{"key":"758_CR21","unstructured":"Government UK. https:\/\/www.gov.uk\/government\/news\/matt-hancock-announces-ambition-to-map-5-million-genomes. Accessed 12 Aug 2020."},{"key":"758_CR22","unstructured":"Genomics England 2020 https:\/\/www.genomicsengland.co.uk\/information-for-participants\/findings\/."},{"key":"758_CR23","unstructured":"Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: World Health Organization;1968."},{"key":"758_CR24","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2471\/BLT.07.050112","volume":"86","author":"A Andermann","year":"2008","unstructured":"Andermann A, Blancquaert I, Beauchamp S, D\u00e9ry V. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ. 2008;86:317\u20139.","journal-title":"Bull World Health Organ"},{"key":"758_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.mayocp.2018.08.028","volume":"94","author":"KB Brothers","year":"2019","unstructured":"Brothers KB, Vassy JL, Green RC. Reconciling opportunistic and population screening in clinical genomics. Mayo Clin Proc. 2019;94:103\u20139.","journal-title":"Mayo Clin Proc."},{"key":"758_CR26","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/s41436-019-0502-5","volume":"21","author":"ACMG Board of Directors.","year":"2019","unstructured":"ACMG Board of Directors. The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2019;21:1467\u20138.","journal-title":"Genet Med."},{"key":"758_CR27","doi-asserted-by":"crossref","unstructured":"Juth N, Munthe C. The Ethics of Screening in Health Care and Medicine. Serving Society or Serving the Patient? Dordrecht Heildelberg London New York: Springer Verlag; 2012.","DOI":"10.1007\/978-94-007-2045-9_6"},{"key":"758_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/oxfordjournals.bmb.a070810","volume":"27","author":"AL Cochrane","year":"1971","unstructured":"Cochrane AL, Holland WW. Validations of screening procedures. Br Med Bull. 1971;27:3\u20138.","journal-title":"Br Med Bull"},{"key":"758_CR29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41431-018-0284-2","volume":"27","author":"L Haer-Wigman","year":"2019","unstructured":"Haer-Wigman L, van der Schoot V, Feenstra I, Vulto-van Silfhout AT, Gilissen C, Brunner HG. et al. 1 in 38 individuals at risk of a dominant medically actionable disease. Eur J Hum Genet. 2019;27:325\u201330. https:\/\/doi.org\/10.1038\/s41431-018-0284-2.","journal-title":"Eur J Hum Genet"},{"key":"758_CR30","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","volume":"50","author":"AV Khera","year":"2018","unstructured":"Khera AV, Chaffin M, Aragam KG, Haas ME, Roselli C, Choi SH, et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations (2018). Nat Genet. 2018;50:1219\u201324.","journal-title":"Nat Genet."},{"key":"758_CR31","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/gim.2013.113","volume":"15","author":"W Burke","year":"2013","unstructured":"Burke W, Antommaria AH, Bennett R, Botkin J, Clayton EW, Henderson GE, et al. Recommendations for returning genomic incidental findings? We need to talk!. Genet Med. 2013;15:854\u20139.","journal-title":"Genet Med."},{"key":"758_CR32","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/gim.2016.90","volume":"19","author":"R Walsh","year":"2017","unstructured":"Walsh R, Thomson KL, Ware JS, et al. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2017;19:192\u2013203. https:\/\/doi.org\/10.1038\/gim.2016.90.","journal-title":"Genet Med."},{"key":"758_CR33","doi-asserted-by":"publisher","unstructured":"Walsh R, Tadros R, Bezzina CR. When genetic burden reaches threshold. Eur Heart J. 2020. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa269.","DOI":"10.1093\/eurheartj\/ehaa269"},{"key":"758_CR34","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1161\/CIRCULATIONAHA.119.043132","volume":"141","author":"A Adler","year":"2020","unstructured":"Adler A, Novelli V, Amin AS, Abiusi E, Care M, Nannenberg EA, et al. An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome. Circulation. 2020;141:418\u201328. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.043132.","journal-title":"Circulation"},{"key":"758_CR35","doi-asserted-by":"publisher","unstructured":"Turner H, Jackson L. Evidence for penetrance in patients without a family history of disease: a systematic review. Eur J Hum Genet. 2020. https:\/\/doi.org\/10.1038\/s41431-019-0556-5.","DOI":"10.1038\/s41431-019-0556-5"},{"key":"758_CR36","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jama.292.8.943","volume":"292","author":"HP Neumann","year":"2004","unstructured":"Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, et al. European-American Paraganglioma Study Group. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA. 2004;292:943\u201351.","journal-title":"JAMA"},{"key":"758_CR37","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/cge.13055","volume":"93","author":"JA Rijken","year":"2018","unstructured":"Rijken JA, Niemeijer ND, Jonker MA, Eijkelenkamp K, Jansen JC, van Berkel A, et al. The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers. Clin Genet. 2018;93:60\u20136.","journal-title":"Clin Genet"},{"key":"758_CR38","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/jmedgenet-2017-105127","volume":"55","author":"KA Andrews","year":"2018","unstructured":"Andrews KA, Ascher DB, Pires DEV, Barnes DR, Vialard L, Casey RT, et al. Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD. J Med Genet. 2018;55:384\u201394.","journal-title":"J Med Genet"},{"key":"758_CR39","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.mayocp.2016.08.008","volume":"91","author":"JP Ackerman","year":"2016","unstructured":"Ackerman JP, Bartos DC, Kapplinger JD, Tester DJ, Delisle BP, Ackerman MJ. The promise and peril of precision medicine: phenotyping still matters most. Mayo Clin Proc. 2016;91:1606\u201316.","journal-title":"Mayo Clin Proc"},{"key":"758_CR40","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1056\/NEJMsa1507092","volume":"375","author":"AK Manrai","year":"2016","unstructured":"Manrai AK, Funke BH, Rehm HL, Olesen MS, Maron BA, Szolovits P, et al. Genetic misdiagnoses and the potential for health disparities. N. Engl J Med. 2016;375:655\u201365.","journal-title":"N. Engl J Med"},{"key":"758_CR41","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1056\/NEJMp1803542","volume":"378","author":"Elmore SNC.","year":"2018","unstructured":"Elmore SNC. P53 and Me. N. Engl J Med. 2018;378:1962\u20133.","journal-title":"N. Engl J Med"},{"key":"758_CR42","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ajhg.2018.07.018","volume":"103","author":"JC Sapp","year":"2018","unstructured":"Sapp JC, Johnston JJ, Driscoll K, Heidlebaugh AR, Miren Sagardia A, Dogbe DN, et al. Evaluation of positive and negative secondary findings evaluations in a hybrid CLIA-research sequencing pilot. Am J Hum genet. 2018;103:358\u201366.","journal-title":"Am J Hum genet"},{"key":"758_CR43","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/s41436-018-0308-x","volume":"21","author":"MR Hart","year":"2019","unstructured":"Hart MR, BieseckerBB, Blout CL, Christensen KD, Amendola LM, Bergstrom KL, et al. Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. Genet Med. 2019;21:1100\u201310.","journal-title":"Genet Med"},{"key":"758_CR44","doi-asserted-by":"publisher","unstructured":"Stefansdottir V, Thorolfsdottir E, Hognason HB, Patch C, Van El C, Hentze, S et al. Web-based return of BRCA2 research results: one-year genetic counselling experience in Iceland. Eur J Hum Genet. 2020. https:\/\/doi.org\/10.1038\/s41431-020-0665-1.","DOI":"10.1038\/s41431-020-0665-1"},{"key":"758_CR45","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1177\/0022146510386794","volume":"51","author":"S Timmermans","year":"2010","unstructured":"Timmermans S, Buchbinder M. Patients-in-waiting: Living between sickness and health in the genomics era. J Health Soc Behav. 2010;51:408\u201323.","journal-title":"J Health Soc Behav"},{"key":"758_CR46","doi-asserted-by":"publisher","first-page":"pii: e001442","DOI":"10.1161\/CIRCGENETICS.116.001442","volume":"10","author":"S Mohammed","year":"2017","unstructured":"Mohammed S, Lim Z, Dean PH, Potts JE, Tang JN, Etheridge SP, et al. Genetic insurance discrimination in sudden arrhythmia death syndromes: empirical evidence from a cross-sectional survey in North America. Circ Cardiovasc Genet. 2017;10:pii: e001442.","journal-title":"Circ Cardiovasc Genet"},{"key":"758_CR47","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1016\/j.jacc.2019.08.1060","volume":"74","author":"AV Khera","year":"2019","unstructured":"Khera AV, Mason-Suares H, Brockman D, Wang M, VanDenburgh MJ, Senol-Cosar O, et al. Rare genetic variants associated with sudden cardiac death in adults. J Am Coll Cardiol. 2019;74:2623\u201334.","journal-title":"J Am Coll Cardiol"},{"key":"758_CR48","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/ACI.0000000000000091","volume":"14","author":"Y Joly","year":"2014","unstructured":"Joly Y, Saulnier KM, Osien G, Knoppers BM. The ethical framing of personalized medicine. Curr Opin Allergy Clin Immunol. 2014;14:404\u20138.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"758_CR49","first-page":"2948","volume":"270","author":"BS Wilfond","year":"1993","unstructured":"Wilfond BS, Nolan K. National policy development for the clinical application of genetic diagnostic technologies. Lessons Cyst Fibros JAMA. 1993;270:2948\u201354.","journal-title":"Lessons Cyst Fibros JAMA"},{"key":"758_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11112-0","volume":"10","author":"L Duncan","year":"2019","unstructured":"Duncan L, Shen H, Gelaye B, Meijsen J, Ressler K, Feldman M, et al. Analysis of polygenic risk score usage and performance in diverse human populations. Nat Commun. 2019;10:3328 https:\/\/doi.org\/10.1038\/s41467-019-11112-0.","journal-title":"Nat Commun"},{"key":"758_CR51","first-page":"1","volume":"10","author":"TM Marteau","year":"2010","unstructured":"Marteau TM, French DP, Griffin SJ, Prevost AT, Sutton S, Watkinson C, et al. Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. Cochrane Libr. 2010;10:1\u201374.","journal-title":"Cochrane Libr"},{"key":"758_CR52","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1126\/science.1239119","volume":"340","author":"SM Wolf","year":"2013","unstructured":"Wolf SM, Annas GJ, Elias S. Point-Counterpoint. Patient autnomy and incidental findings in clinical genomics. Science 2013;340:1049\u201350.","journal-title":"Science"},{"key":"758_CR53","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/humu.22068","volume":"33","author":"W Dondorp","year":"2012","unstructured":"Dondorp W, Sikkema-Raddatz B, de Die-Smulders C, de Wert G. Arrays in postnatal and prenatal diagnosis: an exploration of the ethics of consent. Hum Mutat. 2012;33:916\u201322.","journal-title":"Hum Mutat"},{"key":"758_CR54","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/medethics-2017-104588","volume":"44","author":"S Dheensa","year":"2018","unstructured":"Dheensa S, Samuel S, Lucassen AM, Farsides B. Towards a national genomics medicine service: the challenges facing clinical-research hybrid practices and the case of the 100 000 genomes project. J Med Ethics. 2018;44:397\u2013403.","journal-title":"J Med Ethics"},{"key":"758_CR55","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41431-018-0285-1","volume":"27","author":"D Carrieri","year":"2019","unstructured":"Carrieri D, Howard HC, Benjamin C, Clarke AJ, Dheensa S, Doheny S, et al. Recontacting patients in clinical genetics services: recommendations of the European Society of Human Genetics. Eur J Hum Genet. 2019;27:169\u201382. https:\/\/doi.org\/10.1038\/s41431-018-0285-1.","journal-title":"Eur J Hum Genet"},{"key":"758_CR56","doi-asserted-by":"publisher","first-page":"322ra9","DOI":"10.1126\/scitranslmed.aad5169","volume":"8","author":"EV Minikel","year":"2016","unstructured":"Minikel EV, Vallabh SM, Lek M, Estrada K, Samocha KE, Sathirapongsasuti JF, et al. Quantifying prion disease penetrance using large population control cohorts. Sci Transl Med. 2016;8:322ra9 https:\/\/doi.org\/10.1126\/scitranslmed.aad5169.","journal-title":"Sci Transl Med"},{"key":"758_CR57","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41431-018-0279-z","volume":"27","author":"P Lacaze","year":"2019","unstructured":"Lacaze P, Pinese M, Kaplan W, Stone A, Brion MJ, Woods RL, et al. The Medical Genome Reference Bank: a whole-genome data resource of 4000 healthy elderly individuals. Rationale and cohort design. Eur J Hum Genet. 2019;27:308\u201316. https:\/\/doi.org\/10.1038\/s41431-018-0279-z.","journal-title":"Eur J Hum Genet"},{"key":"758_CR58","doi-asserted-by":"publisher","first-page":"k2611","DOI":"10.1136\/bmj.k2611","volume":"361","author":"Booth Th.","year":"2018","unstructured":"Booth Th. Incidental findings on imaging. BMJ. 2018;361:k2611.","journal-title":"BMJ"},{"key":"758_CR59","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/ejhg.2014.190","volume":"23","author":"F Severin","year":"2015","unstructured":"Severin F, Borry P, Cornel M, Daniels N, Fellmann F, Victoria Hodgson S, et al. Points to consider for prioritizing clinical genetic testing services: a European consensus process oriented at accountability for reasonableness. Eur J Hum Genet. 2015;23:729\u201335.","journal-title":"Eur J Hum Genet"},{"key":"758_CR60","unstructured":"Center for Disease Control Office of Public Health Genomics. 2014. https:\/\/www.cdc.gov\/genomics\/implementation\/toolkit\/tier1.htm. Accessed 3 June 2020."},{"key":"758_CR61","unstructured":"Center for Disease Control Office of Public Health Genomics. 2019. https:\/\/www.cdc.gov\/genomics\/about\/aag\/index.htm. Accessed 17 June 2020."},{"key":"758_CR62","unstructured":"Center for Disease Control Office of Public Health Genomics. 2020a. https:\/\/www.cdc.gov\/genomics\/disease\/breast_ovarian_cancer\/basics_hboc.htm."},{"key":"758_CR63","unstructured":"Center for Disease Control Office of Public Health Genomics. 2020b. https:\/\/www.cdc.gov\/genomics\/disease\/fh\/testing_FH.htm. Accessed 17 June 2020."},{"key":"758_CR64","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10549-013-2669-9","volume":"141","author":"P Pujol","year":"2013","unstructured":"Pujol P, Lyonnet DS, Frebourg T, Blin J, Picot MC, Lasset C, et al. Lack of referral for genetic counseling and testing in BRCA1\/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests. Breast Cancer Res Treat. 2013;141:135\u2013144. https:\/\/doi.org\/10.1007\/s10549-013-2669-9.","journal-title":"Breast Cancer Res Treat"},{"key":"758_CR65","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1001\/jama.2017.3096","volume":"317","author":"KM West","year":"2017","unstructured":"West KM, Blacksher E, Burke W. Genomics, health disparities, and missed opportunities for the nation\u2019s research agenda. JAMA. 2017;317:1831\u20132.","journal-title":"JAMA"},{"key":"758_CR66","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12687-017-0316-6","volume":"8","author":"AR Bentley","year":"2017","unstructured":"Bentley AR, Callier S, Rotimi CN. Diversity and inclusion in genomic research: why the uneven progress? J Community Genet. 2017;8:255\u201366. https:\/\/doi.org\/10.1007\/s12687-017-0316-6.","journal-title":"J Community Genet"},{"key":"758_CR67","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s12687-017-0326-4","volume":"8","author":"JAM Van der Giessen","year":"2017","unstructured":"Van der Giessen JAM, van Riel E, Velthuizen ME, van Dulmen AM, Ausems MGEM. Referral to cancer genetic counseling: do migrant status and patients\u2019 educational background matter? J Community Genet. 2017;8:303\u201310.","journal-title":"J Community Genet"},{"key":"758_CR68","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0140-6736(71)92410-X","volume":"297","author":"Tudor Hart J.","year":"1971","unstructured":"Tudor Hart J. The inverse care law. Lancet. 1971;297:405\u201312.","journal-title":"Lancet"},{"key":"758_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1078-5","volume":"14","author":"B Zamora","year":"2019","unstructured":"Zamora B, Maignen F, O\u2019Neill P, Mestre-Ferrandiz J, Garau M. et al. Comparing access to orphan medicinal products in Europe. Orphanet J Rare Dis. 2019;14:95. https:\/\/doi.org\/10.1186\/s13023-019-1078-5.","journal-title":"Orphanet J Rare Dis"},{"key":"758_CR70","unstructured":"Clarke A. 6n. Oxford: BIOS; 1998."},{"key":"758_CR71","unstructured":"De Wert G. Met het oog op de toekomst (in Dutch). Amsterdam: Thela thesis; 1999."},{"key":"758_CR72","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/ejhg.2009.25","volume":"17","author":"P Borry","year":"2009","unstructured":"Borry P, Evers-Kiebooms G, Cornel M, Clarke A, Dierickx K, Public and Professional Policy Committee (PPPC) of the European Society of Human Genetics (ESHG). Genetic testing in asymptomatic minors. Background document towards ESHG Recommendations. Eur J Hum Genet. 2009;17:711\u20139.","journal-title":"Eur J Hum Genet"},{"key":"758_CR73","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/ejhg.2014.289","volume":"23","author":"HC Howard","year":"2015","unstructured":"Howard HC, Knoppers BM, Cornel MC, Wright Clayton E, S\u00e9n\u00e9cal K, Borry P. Whole-genome sequencing in newborn screening? A statement on the continued importance of targeted approaches in newborn screening programmes. Eur J Hum Genet. 2015;23:1593\u2013600. https:\/\/doi.org\/10.1038\/ejhg.2014.289.","journal-title":"Eur J Hum Genet"},{"key":"758_CR74","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/pd.5102","volume":"38","author":"S Best","year":"2018","unstructured":"Best S, Wou K, Vora N, Van der Veyver IB, Wapner R, Chitty LS. Promises, pitfalls and practicalities of prenatal whole exome sequencing. Prenat Diagn. 2018;38:10\u201319. https:\/\/doi.org\/10.1002\/pd.5102.","journal-title":"Prenat Diagn"},{"key":"758_CR75","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1542\/peds.2018-1099B","volume":"143","author":"JD Lantos","year":"2019","unstructured":"Lantos JD. Ethical and Psychosocial Issues in Whole Genome Sequencing (WGS) for Newborns. Pediatrics 2019;143:S1\u2013S5. https:\/\/doi.org\/10.1542\/peds.2018-1099B.","journal-title":"Pediatrics"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41431-020-00758-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-020-00758-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41431-020-00758-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:01:06Z","timestamp":1684616466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-020-00758-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,22]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["758"],"URL":"https:\/\/doi.org\/10.1038\/s41431-020-00758-w","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,22]]},"assertion":[{"value":"14 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}